Mitochondrial gene expression is required for platelet function and blood clotting

Area of Science:

• Hematology
• Mitochondrial Biology
• Molecular Genetics

Background:

• Platelets are anucleate blood cells critical for hemostasis.
• Mitochondria possess their own gene expression machinery, but its autonomy from the nucleus is not fully understood.
• Nuclear-encoded factors are essential for mitochondrial oxidative phosphorylation and energy production in platelets.

Purpose of the Study:

• To investigate the role of specific mitochondrial gene expression factors (ELAC2, PTCD1, MTIF3) in anucleate platelets.
• To elucidate the importance of mitochondrial gene expression autonomy in platelet function.
• To understand the impact of impaired mitochondrial gene expression on hemostasis and thrombosis.

Main Methods:

• Conditional deletion of Elac2, Ptcd1, and Mtif3 genes in mouse platelets.
• Analysis of megakaryocyte ploidy, platelet counts, and reticulated platelet levels.
• Assessment of bleeding time and platelet activation.
• Transcriptomic and proteomic analyses to evaluate molecular changes.

Main Results:

• Deletion of ELAC2, PTCD1, or MTIF3 resulted in increased megakaryocyte ploidy and elevated circulating reticulated platelets.
• Loss of these factors led to thrombocytopenia and prolonged bleeding times.
• Impaired mitochondrial gene expression significantly reduced agonist-induced platelet activation.
• Mitochondrial gene expression was found to be essential for fibrinolysis, hemostasis, and blood coagulation.

Conclusions:

• Mitochondrial gene expression, regulated by ELAC2, PTCD1, and MTIF3, is vital for platelet biogenesis and function.
• Disruption of mitochondrial gene expression pathways in platelets has profound effects on hemostasis and bleeding.
• Platelets serve as a valuable model for studying mitochondrial gene expression autonomy in anucleate cells.